story of the week
No Survival Advantage With Tremelimumab in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
J. Clin. Oncol 2013 Jan 07;[EPub Ahead of Print], A Ribas, R Kefford, MA Marshall, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.